Date Name Title Filing Type Shares Traded Price Total Held
Dec 18, 2003
Director
Director Form 4 Conversion of derivative security 25,000 -- 76,237
Dec 17, 2003
Director
Director Form 4 Other acquisition or disposition -- -- 200,000
Dec 15, 2003
SVP Fin & Admin, CFO, & Treas
SVP Fin & Admin, CFO, & Treas Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,708 -- 31,108
Dec 15, 2003
SVP Fin & Admin, CFO, & Treas
SVP Fin & Admin, CFO, & Treas Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 7,692 -- 7,692
Dec 15, 2003
SVP Fin & Admin, CFO, & Treas
SVP Fin & Admin, CFO, & Treas Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 67,308 -- 67,308
Dec 15, 2003
VP, Clinical Sciences
VP, Clinical Sciences Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,077 -- 12,124
Dec 15, 2003
VP, Clinical Sciences
VP, Clinical Sciences Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 -- 5,000
Dec 15, 2003
VP, Clinical Sciences
VP, Clinical Sciences Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 -- 15,000
Dec 15, 2003
VP, Gen Counsel & Secretary
VP, Gen Counsel & Secretary Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,485 -- 12,145
Dec 15, 2003
VP, Gen Counsel & Secretary
VP, Gen Counsel & Secretary Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 7,692 -- 7,692

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.